Ana Teijo-Quintans

5PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 28, 2025
Correction: Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

|Mar 12, 2025
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

|Feb 04, 2025
Squamous cell carcinoma arising in a tailgut cyst: role of radiotherapy.

Diego Aldave, Ana Teijo, Claudia Abril

|Aug 08, 2024
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).

Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso

|Feb 16, 2023
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms.

Beatriz Soldevilla, Alberto Lens-Pardo, Paula Espinosa-Olarte

Pageof 1

Frequent Collaborators

2 joint publications

Mar Iglesias Coma

2 joint publications

Fernando Rivera Herrero

2 joint publications

Rocio Garcia-Carbonero

2 joint publications

Carolina Martínez Ciarpaglini